PharmaTimes October 19, 2023
The considerations will help to develop new or existing guidance on AI
The World Health Organization (WHO) has published new key regulatory considerations on artificial intelligence (AI) for health to emphasise the importance of establishing the safety and effectiveness of AI systems.
The new considerations aim to help governments and regulatory authorities to develop new guidance or adapt existing guidance on AI at national or regional levels.
With AI rapidly being deployed, WHO has recognised the benefits it has had for health outcomes by strengthening clinical trials, improving medical diagnosis, treatment, self-care and person-centred care, as well as supporting health care professionals’ (HCPs) knowledge, skills and competencies.
Despite this, some AI technologies are being deployed without a full understanding of...
Today's Sponsors
Today's Sponsor